(Q40787693)

English

Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate with vascular density or the expression of VEGF, FLK1 or FLT1.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate with vascular density or the expression of VEGF, FLK1 or FLT1. (English)

1 reference

Europe PubMed Central

23 September 2017

0 references

author name string

Soini Y

1

1 reference

Europe PubMed Central

23 September 2017

Puhakka A

2

1 reference

Europe PubMed Central

23 September 2017

Kahlos K

3

1 reference

Europe PubMed Central

23 September 2017

Säily M

4

1 reference

Europe PubMed Central

23 September 2017

Pääkkö P

5

1 reference

Europe PubMed Central

23 September 2017

Koistinen P

6

1 reference

Europe PubMed Central

23 September 2017

Kinnula V

7

1 reference

Europe PubMed Central

23 September 2017

publication date

1 August 2001

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

39

1 reference

Europe PubMed Central

23 September 2017

2

1 reference

Europe PubMed Central

23 September 2017

179-186

1 reference

Europe PubMed Central

23 September 2017

Malignant pleural mesothelioma: some aspects of epidemiology, differential diagnosis and prognosis. Histological and immunohistochemical evaluation and follow-up of mesotheliomas diagnosed from 1964 to January 1985.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

Vascular endothelial growth factor: possible role in fetal development and placental function

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR)

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

Expression of inducible nitric oxide synthase in healthy pleura and in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

Molecular cloning and characterization of human endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

Role of nitric oxide in tumor progression: lessons from experimental tumors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

Role of nitric oxide in tumour progression: lessons from human tumours

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

Significant correlation of nitric oxide synthase activity and p53 gene mutation in stage I lung adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

Nitric oxide synthase activity in human lung cancer.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

Roles of nitric oxide in tumor growth

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

Proliferation, apoptosis, and manganese superoxide dismutase in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01211.X

21 January 2018

Identifiers

10.1046/J.1365-2559.2001.01211.X

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40787693&oldid=2039017872"